1. United States of America Stocks

  2. •

    Financial Services

  3. •

    Shell Companies
Kasten, Inc.

Kasten, Inc.

KAST
Kasten, Inc.US flagOther OTC
4.00
USD
+3.97
- -
164.56MMarket Cap
No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChatGPT
CEO
Jingwei Zhang
Sector
Financial Services
Industry
Shell Companies
Address
522 North Main Avenue Sioux Falls SD United States of America 57104
IPO Date
Feb 1, 1995
CIK
0001701782
Similar Companies
FIGX Capital Acquisition Corp. Warrant (FIGXW)
Fragrant Prosperity Holdings Limited (FPP.L)
1RT Acquisition Corp. (ONCH)
Investcorp Europe Acquisition Corp I (IVCBU)
Aifeex Nexus Acquisition Corp (AIFEU)
G&P Acquisition Corp. (GAPA)
Business
Kasten, Inc. functions as a biopharmaceutical enterprise, concentrating its efforts on identifying, advancing, and commercializing medicinal therapies intended to address and avert critical ailments prevalent in both clinical and community environments. The company primarily aims to provide effective options for individuals grappling with antimicrobial resistance, striving to make vital pharmaceutical products accessible. Leveraging its Site Specific Penetration Technology (SSPT™), acquired through its integration with DAKOTA Life Sciences, Kasten develops a range of topical antibiotics and antifungals, including those targeting resistant bacterial infections like MRSA. Established in 1986, the firm is headquartered in Sioux Falls, South Dakota.